BioMarin doses first patient in global GENEr8-1 Phase 3 study
BioMarin Pharmaceutical has dosed the first patient in the global GENEr8-1 Phase 3 study with the 6e13 vg/kg dose for…
Pharmaceuticals, Biotechnology and Life Sciences
BioMarin Pharmaceutical has dosed the first patient in the global GENEr8-1 Phase 3 study with the 6e13 vg/kg dose for…
The U.S. Food and Drug Administration (FDA) has granted 510(k) marketing clearance to Shire’s myPKFiT for ADVATE, a free web-based…
Pfenex has announced the amendment of the 2016 agreement under which Pfenex granted Jazz Pharmaceuticals worldwide rights to develop and…
Hikma Pharmaceuticals has reached a licensing agreement with South Korea-based Celltrion, Inc. and Celltrion Healthcare, Inc (Celltrion) for the first…
Sanofi Genzyme, the specialty care global business unit of Sanofi, and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the RNAi therapeutics company,…
Allergan has announced that Wayne Swanton has been promoted to Executive Vice President, Global Operations following notification that Rob Stewart,…
Bristol-Myers Squibb Company (NYSE:BMY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines…
The US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for the use of AstraZeneca’s…
Horizon Discovery Group has entered into an agreement with Roche Diagnostics to assist in the development of immunohistochemistry (IHC) assays.
According to the press release from Thursday, Teva said it needs to reduce total cost base by $3 billion by the end…